Literature DB >> 8477810

Essential role of tumor necrosis factor-alpha in the differentiation of human tonsil in vivo induced B cells capable of spontaneous and high-rate immunoglobulin secretion.

C Rodríguez1, E Roldán, G Navas, J A Brieva.   

Abstract

Human tonsils contain B cells capable of spontaneous and high-rate immunoglobulin (Ig) secretion in vitro. These cells are in vivo induced mature B cells, and, as such, they provide and adequate model for studying tonsil B cell differentiation. The present report analyzes the effect of a variety of factors on purified tonsil B cells capable of spontaneous IgG secretion in fetal calf serum (FCS)-containing and serum-free supplemented cultures. Tumor necrosis factor-(TNF) alpha was found to be important for these B cells to reach the high-rate IgG-secreting stage, as is indicated by the following findings: (a) none of the factors used modified tonsil B cell IgG secretion in FCS-containing cultures; (b) TNF-alpha (5-20 ng/ml), but not other cytokines or factors including interleukin (IL)-6, was capable of restoring missing IgG production in serum-free supplemented cultures of tonsil B cells; and (c) IgG secretion in FCS-containing cultures was inhibited by the addition of blocking anti-TNF-alpha antibodies, but not anti-IL-6 antibodies, and this inhibition could be specifically reversed by exogenous TNF-alpha. TNF-alpha was actively produced by tonsil B cells (range 120-750 pg/ml) in the presence, but not in the absence, of FCS. The TNF-alpha inductive effect occurred during the first 12 h of culture and did not require DNA synthesis. These results indicate that the early and endogenous generation of TNF-alpha seems to be essential for tonsil in vivo induced B cells to differentiate into the high-rate Ig-secreting stage.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8477810     DOI: 10.1002/eji.1830230527

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  Sustained secretion of immunoglobulin by long-lived human tonsil plasma cells.

Authors:  Jacob M van Laar; Marc Melchers; Y K Onno Teng; Boris van der Zouwen; Rozbeh Mohammadi; Randy Fischer; Leonid Margolis; Wendy Fitzgerald; Jean-Charles Grivel; Ferdinand C Breedveld; Peter E Lipsky; Amrie C Grammer
Journal:  Am J Pathol       Date:  2007-08-09       Impact factor: 4.307

Review 2.  The CD40 ligand. At the center of the immune universe?

Authors:  I S Grewal; R A Flavell
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

Review 3.  Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system.

Authors:  H Y Wu; M W Russell
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

4.  Differentiation of pancreatic ductal carcinoma cells associated with selective expression of protein kinase C isoforms.

Authors:  M G Franz; J G Norman; P J Fabri; W R Gower
Journal:  Ann Surg Oncol       Date:  1996-11       Impact factor: 5.344

5.  Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer.

Authors:  J Kolls; K Peppel; M Silva; B Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

6.  B cells capable of spontaneous IgG secretion in cerebrospinal fluid from patients with multiple sclerosis: dependency on local IL-6 production.

Authors:  L Perez; J C Alvarez-Cermeño; C Rodriguez; E Roldán; J A Brieva
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

7.  Synergistic stimulation of human B lymphocytes by anti-CD40 monoclonal antibodies and synthetic lipopeptide analogues from Escherichia coli lipoprotein.

Authors:  M Edinger; W G Bessler; B Kleine
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

8.  Activation of human dendritic cells through CD40 cross-linking.

Authors:  C Caux; C Massacrier; B Vanbervliet; B Dubois; C Van Kooten; I Durand; J Banchereau
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

9.  RANTES and macrophage inflammatory protein 1 alpha selectively enhance immunoglobulin (IgE) and IgG4 production by human B cells.

Authors:  H Kimata; A Yoshida; C Ishioka; M Fujimoto; I Lindley; K Furusho
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.